{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:43:55Z","timestamp":1782301435514,"version":"3.54.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,27]]},"DOI":"10.7759\/cureus.49494","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T15:24:35Z","timestamp":1701098675000},"source":"Crossref","is-referenced-by-count":1,"title":["Amiodarone-Induced Electrical Storm: A Nightmare in the Emergency Room"],"prefix":"10.7759","author":[{"given":"Andreia","family":"Campinas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Pereira Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jo\u00e3o","family":"Sousa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severo","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC","volume":"42","author":"Hindricks G","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al.. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021, 42:373-498. 10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(83)90270-3","article-title":"Amiodarone-induced polymorphous ventricular tachycardia","volume":"105","author":"Sclarovsky S","year":"1983","unstructured":"Sclarovsky S, Lewin RF, Kracoff O, Strasberg B, Arditti A, Agmon J. Amiodarone-induced polymorphous ventricular tachycardia. Am Heart J. 1983, 105:6-12. 10.1016\/0002-8703(83)90270-3","journal-title":"Am Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/ajem.2001.22655","article-title":"Amiodarone-induced long QT and polymorphic ventricular tachycardia","volume":"19","author":"Nkomo VT","year":"2001","unstructured":"Nkomo VT, Shen WK. Amiodarone-induced long QT and polymorphic ventricular tachycardia. Am J Emerg Med. 2001, 19:246-8. 10.1053\/ajem.2001.22655","journal-title":"Am J Emerg Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5273(86)90121-X","article-title":"Amiodarone and hypokalemia. A dangerous combination","volume":"13","author":"Moro C","year":"1986","unstructured":"Moro C, Romero J, Corres Peiretti MA. Amiodarone and hypokalemia. A dangerous combination. Int J Cardiol. 1986, 13:365-8. 10.1016\/0167-5273(86)90121-X","journal-title":"Int J Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehac262","article-title":"2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"43","author":"Zeppenfeld K","year":"2022","unstructured":"Zeppenfeld K, Tfelt-Hansen J, de Riva M, et al.. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2022, 43:3997-4126. 10.1093\/eurheartj\/ehac262","journal-title":"Eur Heart J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000549","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society","volume":"138","author":"Al-Khatib SM","year":"2018","unstructured":"Al-Khatib SM, Stevenson WG, Ackerman MJ, et al.. 2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2018, 138:e272-391. 10.1161\/CIR.0000000000000549","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/0033-0620(88)90014-X","article-title":"The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis","volume":"31","author":"Jackman WM","year":"1988","unstructured":"Jackman WM, Friday KJ, Anderson JL, Aliot EM, Clark M, Lazzara R. The long QT syndromes: a critical review, new clinical observations and a unifying hypothesis. Prog Cardiovasc Dis. 1988, 31:115-72. 10.1016\/0033-0620(88)90014-X","journal-title":"Prog Cardiovasc Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.rec.2011.05.018","article-title":"Proarrhythmic potential of amiodarone: an underestimated risk?","volume":"65","author":"Jurado Rom\u00e1n A","year":"2012","unstructured":"Jurado Rom\u00e1n A, Rubio Alonso B, Mart\u00edn Asenjo R, Salguero Bodes R, L\u00f3pez Gil M, Arribas Ynsaurriaga F. Proarrhythmic potential of amiodarone: an underestimated risk?. Rev Esp Cardiol (Engl Ed). 2012, 65:292-4. 10.1016\/j.rec.2011.05.018","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.3539","article-title":"Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation","volume":"9","author":"Nordkin I","year":"2021","unstructured":"Nordkin I, Levinas T, Rosenfeld I, Halabi M. Torsades de pointes after prolonged intravenous amiodarone therapy for atrial fibrillation. Clin Case Rep. 2021, 9:391-4. 10.1002\/ccr3.3539","journal-title":"Clin Case Rep"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jelectrocard.2019.06.009","article-title":"QT correction in atrial fibrillation - measurement revisited","volume":"56","author":"Dash A","year":"2019","unstructured":"Dash A, Torado C, Paw N, Fan D, Pezeshkian N, Srivatsa U. QT correction in atrial fibrillation - measurement revisited. J Electrocardiol. 2019, 56:70-6. 10.1016\/j.jelectrocard.2019.06.009","journal-title":"J Electrocardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(00)00564-7","article-title":"Tiapride-induced torsade de pointes","volume":"109","author":"Iglesias E","year":"2000","unstructured":"Iglesias E, Esteban E, Zabala S, Gascon A. Tiapride-induced torsade de pointes. Am J Med. 2000, 109:509. 10.1016\/S0002-9343(00)00564-7","journal-title":"Am J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(01)01011-7","article-title":"Clinical and therapeutic aspects of congenital and acquired long QT syndrome","volume":"112","author":"Khan IA","year":"2002","unstructured":"Khan IA. Clinical and therapeutic aspects of congenital and acquired long QT syndrome. Am J Med. 2002, 112:58-66. 10.1016\/S0002-9343(01)01011-7","journal-title":"Am J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrcr.2018.08.013","article-title":"Isoproterenol suppresses recurrent torsades de pointes in a patient with long QT syndrome type 2","volume":"4","author":"Suarez K","year":"2018","unstructured":"Suarez K, Mack R, Hardegree EL, Chiles C, Banchs JE, Gonzalez MD. Isoproterenol suppresses recurrent torsades de pointes in a patient with long QT syndrome type 2. HeartRhythm Case Rep. 2018, 4:576-9. 10.1016\/j.hrcr.2018.08.013","journal-title":"HeartRhythm Case Rep"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1542-474x.2002.tb00182.x","article-title":"Effects of sympathetic stimulation on various repolarization indices in the congenital long QT syndrome","volume":"7","author":"Shimizu W","year":"2002","unstructured":"Shimizu W. Effects of sympathetic stimulation on various repolarization indices in the congenital long QT syndrome. Ann Noninvasive Electrocardiol. 2002, 7:332-42. 10.1111\/j.1542-474x.2002.tb00182.x","journal-title":"Ann Noninvasive Electrocardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/207561-amiodarone-induced-electrical-storm-a-nightmare-in-the-emergency-room","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:06:53Z","timestamp":1707509213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/207561-amiodarone-induced-electrical-storm-a-nightmare-in-the-emergency-room"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,27]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.49494","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,27]]}}}